MolProbity logo

All-Atom
Contacts
Clashscore, all atoms:54.81 3rd percentile* (N=1784, all resolutions)
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms.
Protein
Geometry
Poor rotamers0.00% Goal: <1%
Ramachandran outliers0.00% Goal: <0.2%
Ramachandran favored95.54% Goal: >98%
Cβ deviations >0.25Å0 Goal: 0
MolProbity score^2.5246th percentile* (N=27675, 0Å - 99Å)
Residues with bad bonds:0.00% Goal: 0%
Residues with bad angles:1.75% Goal: <0.1%
* 100th percentile is the best among structures of comparable resolution; 0th percentile is the worst.
^ MolProbity score is defined as the following: 0.42574*log(1+clashscore) + 0.32996*log(1+max(0,pctRotOut-1)) + 0.24979*log(1+max(0,100-pctRamaFavored-2)) + 0.5

Bond angles.
Avg: 0.00Clashscore: 54.81Outliers: 0 of 112Poor rotamers: 0 of 99Outliers: 0 of 106Outliers: 0 of 114Outliers: 2 of 114
A1002 ASP0--20.2% (t0)
chi angles: 183.9,137.2
0.005Å--
A1003 PRO00.507Å
CD with A1027 ASN O
Favored (8.74%)
Proline / -91.1,154.8
32% (Cg_exo)
chi angles: 338.9
0.04Å--
A1004 ILE0-Favored (29.8%)
General case / -140.2,132.8
83.7% (mt)
chi angles: 300.8,171.5
0.037Å--
A1005 TYR0-Favored (23.65%)
General case / -155.2,168.6
53.2% (p90)
chi angles: 62.6,93.8
0.015Å--
A1006 PHE00.967Å
CZ with A1092 LEU CD2
Favored (36.21%)
General case / -79.5,140.1
29.3% (m-85)
chi angles: 289.4,127.2
0.018Å--
A1007 ALA00.489Å
CB with A1025 LEU CD1
Favored (4.04%)
General case / -152.1,115.8
-0.057Å--
A1008 GLU0-Favored (95.66%)
Pre-proline / -71.7,147.6
98.3% (mt-10)
chi angles: 293.6,181.7,171.7
0.008Å--
A1009 PRO0-Favored (12.42%)
Proline / -77.8,-23.7
67.9% (Cg_endo)
chi angles: 28
0.039Å--
A1010 ARG0-Favored (53.61%)
General case / -123.1,141.8
85.6% (mtt85)
chi angles: 293.7,180.6,176.5,88.9
0.025Å--
A1011 VAL0-Favored (55.35%)
General case / -130.1,129.1
99.8% (t)
chi angles: 178.5
0.04Å--
A1012 VAL0-Favored (56.41%)
General case / -107.9,119.6
99.8% (t)
chi angles: 178.5
0.058Å--
A1013 ARG01.191Å
CZ with A1020 ALA CB
Favored (41.08%)
General case / -130.8,161.2
84.1% (mtp180)
chi angles: 297.1,179.6,66.7,188.4
0.007Å--
A1014 VAL0-Favored (25.68%)
General case / -102.7,148.5
35.5% (m)
chi angles: 297.9
0.044Å--
A1015 GLN0-Favored (74.55%)
General case / -64.8,-31.1
64% (tt0)
chi angles: 183.6,176.4,29.7
0.002Å--
A1016 GLU0-Favored (66.11%)
General case / -69.7,-23.5
99.4% (mt-10)
chi angles: 292.3,179.9,177.1
0.01Å--
A1017 GLY0-Favored (83.03%)
Glycine / -55.7,-41.0
----
A1018 GLU0-Allowed (0.22%)
General case / 75.9,-21.4
90% (mt-10)
chi angles: 296.9,180.8,9.2
0.011Å--
A1019 THR00.828Å
C with A1013 ARG NH1
Favored (10.99%)
General case / -160.3,143.3
8.8% (t)
chi angles: 182.7
0.025Å--
A1020 ALA01.191Å
CB with A1013 ARG CZ
Favored (40.58%)
General case / -143.6,153.2
-0.03Å--
A1021 ASN0-Favored (45.66%)
General case / -100.2,134.8
85.2% (m-20)
chi angles: 293.9,313.8
0.039Å--
Bond angles.
Avg: 0.00Clashscore: 54.81Outliers: 0 of 112Poor rotamers: 0 of 99Outliers: 0 of 106Outliers: 0 of 114Outliers: 2 of 114
A1022 PHE00.527Å
CE2 with A1109 VAL CG2
Favored (52.43%)
General case / -119.0,140.6
93.6% (m-85)
chi angles: 295.5,86
0.045Å--
A1023 THR0-Favored (49.9%)
General case / -133.9,147.2
68.4% (p)
chi angles: 62
0.007Å--
A1024 VAL0-Favored (48.37%)
General case / -121.1,143.1
9.1% (p)
chi angles: 60.3
0.053Å--
A1025 LEU00.489Å
CD1 with A1007 ALA CB
Favored (31.44%)
General case / -118.1,155.7
6.7% (mp)
chi angles: 289.7,77.8
0.014Å--
A1026 ARG00.454Å
NH2 with A1029 SER O
Favored (60.67%)
General case / -127.8,133.8
68.7% (ttp85)
chi angles: 181.5,172.5,64.7,88.7
0.042Å--
A1027 ASN00.507Å
O with A1003 PRO CD
Favored (52.43%)
General case / -130.1,155.5
67.5% (m-80)
chi angles: 294.7,281.5
0.032Å--
A1028 GLY0-Favored (10.02%)
Glycine / 106.0,-147.2
----
A1029 SER00.454Å
O with A1026 ARG NH2
Favored (17.17%)
General case / -70.2,120.0
33.7% (t)
chi angles: 175.4
0.007Å--
A1030 VAL0-Favored (41.55%)
General case / -80.9,-22.1
32.9% (m)
chi angles: 300.2
0.02Å--
A1031 ASP01.022Å
O with A1065 VAL CG2
Favored (69.46%)
General case / -62.0,-26.3
99.2% (m-20)
chi angles: 288.1,165.7
0.034Å--
A1032 VAL0-Favored (21.98%)
General case / -111.0,158.0
34.2% (m)
chi angles: 299
0.025Å--
A1033 THR0-Favored (48%)
General case / -70.3,142.7
96.4% (m)
chi angles: 299.6
0.035Å--
A1034 CYS0-Favored (36.04%)
General case / -147.1,155.5
73.4% (m)
chi angles: 296.9
0.018Å--
A1035 MET00.484Å
N with A1096 THR CG2
Favored (35.12%)
General case / -148.2,154.5
75.4% (mtm)
chi angles: 296,179.2,286.4
0.013Å--
A1036 VAL0-Favored (28.9%)
General case / -149.8,146.3
14.8% (p)
chi angles: 63.8
0.061Å--
A1037 GLN0-Favored (28.84%)
General case / -109.3,150.1
93.8% (mt-30)
chi angles: 296,181.3,315.1
0.026Å--
A1038 TYR00.894Å
OH with A1057 LYS CE
Favored (54.76%)
General case / -132.2,154.2
53.1% (p90)
chi angles: 64.8,91.2
0.032Å--
A1039 ALA0-Favored (34.94%)
General case / -146.2,145.7
-0.041Å--
A1040 THR0-Favored (30.68%)
General case / -78.3,153.3
81.6% (p)
chi angles: 61
0.045Å--
A1041 LYS0-Favored (54.22%)
General case / -132.8,151.5
74.9% (mmtt)
chi angles: 299,291,182.8,184.3
0.024Å--
Bond angles.
Avg: 0.00Clashscore: 54.81Outliers: 0 of 112Poor rotamers: 0 of 99Outliers: 0 of 106Outliers: 0 of 114Outliers: 2 of 114
A1042 ASP0-Favored (45.58%)
General case / -70.7,149.0
97.3% (m-20)
chi angles: 289.4,167.2
0.026Å--
A1043 GLY0-Favored (4.1%)
Glycine / -144.6,-145.7
----
A1044 LYS0-Favored (77.91%)
General case / -64.2,-33.2
98.3% (mttt)
chi angles: 289.9,179.8,179.5,178.3
0.046Å--
A1045 ALA00.538Å
CA with A1051 ASP OD2
Favored (28.93%)
General case / -79.1,155.5
-0.037Å--
A1046 THR00.541Å
N with A1051 ASP OD2
Favored (38.81%)
General case / -107.1,141.4
67.8% (p)
chi angles: 59.6
0.017Å--
A1047 ALA0-Favored (30.92%)
General case / -108.6,147.5
-0.024Å--
A1048 ARG0-Favored (13.79%)
General case / 54.6,32.4
24.3% (ttt85)
chi angles: 203.6,161.8,170.3,92.7
0.052Å--
A1049 GLU00.569Å
O with A1053 ILE CG1
Allowed (0.91%)
General case / -159.5,-161.4
79.8% (mm-40)
chi angles: 296.1,291,158.7
0.049Å--
A1050 ARG00.618Å
CA with A1053 ILE CG1
Favored (73.54%)
General case / -54.7,-46.7
71% (ttp85)
chi angles: 181.8,184.4,63.5,78.7
0.054Å--
A1051 ASP00.541Å
OD2 with A1046 THR N
Favored (65.49%)
General case / -67.7,-50.4
26.1% (m-20)
chi angles: 288.8,109.2
0.026Å--
A1052 PHE01.326Å
CZ with A1088 PHE CE2
Allowed (1.67%)
General case / -122.8,79.3
31.7% (m-85)
chi angles: 299.9,73.7
0.056Å--
A1053 ILE01.263Å
CD1 with A1077 ASN ND2
Favored (18.98%)
Pre-proline / -69.2,-45.9
97.3% (mt)
chi angles: 293.2,168.4
0.031Å--
A1054 PRO00.583Å
CD with A1077 ASN CB
Favored (49.33%)
Proline / -67.3,-26.1
50.6% (Cg_exo)
chi angles: 335.7
0.004Å--
A1055 VAL00.496Å
CG1 with A1075 PHE N
Favored (2.98%)
General case / -157.8,118.7
10% (p)
chi angles: 60.9
0.047Å-1 OUTLIER(S)
worst is C-N-CA: -7.049 &sigma
A1056 GLU0-Favored (26.09%)
General case / -88.3,145.9
42.8% (tt0)
chi angles: 184.2,177.8,65.3
0.108Å-1 OUTLIER(S)
worst is N-CA-C: -4.889 &sigma
A1057 LYS00.894Å
CE with A1038 TYR OH
Favored (49.43%)
General case / -133.7,144.0
87.9% (tttt)
chi angles: 182.1,177.9,179.8,182.1
0.016Å--
A1058 GLY00.476Å
O with A1059 GLU CG
Favored (4.68%)
Glycine / -142.3,129.5
----
A1059 GLU00.476Å
CG with A1058 GLY O
Favored (15.25%)
General case / -156.7,173.3
78.3% (mm-40)
chi angles: 295,289.9,159.4
0.003Å--
A1060 THR0-Favored (61.74%)
General case / -109.9,128.5
98.3% (m)
chi angles: 299
0.046Å--
A1061 LEU00.611Å
CD2 with A1038 TYR CE2
Favored (56.54%)
General case / -104.4,121.9
90.6% (mt)
chi angles: 300.1,176.6
0.051Å--
Bond angles.
Avg: 0.00Clashscore: 54.81Outliers: 0 of 112Poor rotamers: 0 of 99Outliers: 0 of 106Outliers: 0 of 114Outliers: 2 of 114
A1062 ILE0-Favored (62.17%)
General case / -111.7,129.7
91.9% (mt)
chi angles: 298.6,169.9
0.04Å--
A1063 PHE0-Favored (33.5%)
General case / -112.5,113.1
88.4% (m-85)
chi angles: 295,83.3
0.036Å--
A1064 GLU0-Favored (25.11%)
General case / -76.8,163.2
81.4% (mm-40)
chi angles: 296.7,293.3,154
0.041Å--
A1065 VAL01.022Å
CG2 with A1031 ASP O
Favored (51.37%)
General case / -62.7,134.1
12% (p)
chi angles: 66.1
0.052Å--
A1066 GLY0-Favored (61.4%)
Glycine / 98.7,-3.9
----
A1067 SER0-Favored (57.2%)
General case / -111.6,120.4
36.1% (t)
chi angles: 175.8
0.015Å--
A1068 ARG0-Favored (43.4%)
General case / -79.1,-34.7
99.8% (mtt180)
chi angles: 291,178.4,179.7,174.8
0.03Å--
A1069 GLN0-Favored (36.33%)
General case / -142.2,161.5
21.1% (pt20)
chi angles: 64.1,183,70.9
0.002Å--
A1070 GLN0-Favored (48.95%)
General case / -135.4,146.8
72.5% (tp60)
chi angles: 180.5,67,55.7
0.027Å--
A1071 SER0-Favored (50.57%)
General case / -127.4,149.6
96.6% (p)
chi angles: 63.8
0.024Å--
A1072 ILE00.423Å
CB with A1057 LYS NZ
Favored (39.28%)
General case / -144.6,150.0
2.6% (pp)
chi angles: 63.3,90.4
0.047Å--
A1073 SER0-Favored (24.97%)
General case / -104.7,150.8
93% (p)
chi angles: 63.1
0.019Å--
A1074 ILE0-Favored (59.03%)
General case / -128.7,136.5
88.9% (mt)
chi angles: 299.4,170.6
0.046Å--
A1075 PHE00.496Å
N with A1055 VAL CG1
Favored (42.94%)
General case / -95.4,134.0
91.8% (m-85)
chi angles: 292.8,85.6
0.004Å--
A1076 VAL0-Favored (27.52%)
General case / -102.0,146.3
12.4% (p)
chi angles: 62.3
0.056Å--
A1077 ASN01.263Å
ND2 with A1053 ILE CD1
Favored (55.83%)
General case / -101.6,125.0
27% (t30)
chi angles: 184.4,74.4
0.027Å--
A1078 GLU0-Favored (17.53%)
General case / -89.3,158.1
25.2% (pt-20)
chi angles: 66.2,180.9,25.1
0.014Å--
A1079 ASP0-Favored (12.34%)
General case / -161.6,173.8
20.6% (p30)
chi angles: 60.7,33.2
0.014Å--
A1080 GLY0-Allowed (0.36%)
Glycine / -114.1,65.6
----
A1081 ILE0-Favored (20%)
Pre-proline / -142.3,137.8
85.4% (mt)
chi angles: 300.3,171.1
0.054Å--
Bond angles.
Avg: 0.00Clashscore: 54.81Outliers: 0 of 112Poor rotamers: 0 of 99Outliers: 0 of 106Outliers: 0 of 114Outliers: 2 of 114
A1082 PRO0-Favored (52.74%)
Proline / -73.1,147.2
56.9% (Cg_endo)
chi angles: 26.1
0.039Å--
A1083 GLU00.531Å
OE1 with A1050 ARG NH2
Favored (30.88%)
General case / -153.1,163.9
23.2% (pt-20)
chi angles: 63.6,183.2,174.5
0.028Å--
A1084 THR0-Favored (4.39%)
General case / -97.4,-179.0
56.6% (p)
chi angles: 65.3
0.044Å--
A1085 ASP0-Favored (52.68%)
General case / -65.5,143.0
97.3% (m-20)
chi angles: 289.4,167.3
0.03Å--
A1086 GLU0-Favored (12.46%)
Pre-proline / -148.3,135.9
57.9% (mt-10)
chi angles: 296.5,181,122.4
0.011Å--
A1087 PRO0-Allowed (1.85%)
Proline / -101.8,162.9
94.3% (Cg_endo)
chi angles: 32.2
0.053Å--
A1088 PHE01.326Å
CE2 with A1052 PHE CZ
Favored (31.05%)
General case / -145.0,163.3
7.6% (p90)
chi angles: 64.4,111.9
0.053Å--
A1089 TYR0-Favored (48.89%)
General case / -126.3,151.8
94.4% (m-85)
chi angles: 298.1,87.3
0.006Å--
A1090 ILE0-Favored (62.09%)
General case / -113.3,126.6
5.1% (mp)
chi angles: 298.9,85.9
0.077Å--
A1091 ILE00.507Å
CG1 with A1106 VAL CG2
Favored (40.08%)
General case / -120.0,148.3
20.6% (tt)
chi angles: 187.3,165.9
0.029Å--
A1092 LEU00.967Å
CD2 with A1006 PHE CZ
Favored (29.62%)
General case / -105.0,146.3
85.7% (mt)
chi angles: 301.4,176.3
0.019Å--
A1093 LEU0-Favored (11.4%)
General case / -164.0,172.8
2.7% (pt?)
chi angles: 71.4,166.6
0.01Å--
A1094 ASN0-Favored (13.52%)
General case / 54.6,50.8
87.8% (m-20)
chi angles: 296.5,320.3
0.015Å--
A1095 SER00.462Å
CB with A1099 THR OG1
Favored (35.89%)
General case / -71.7,155.2
85.9% (p)
chi angles: 68
0.036Å--
A1096 THR00.484Å
CG2 with A1035 MET N
Favored (6.53%)
General case / -65.0,168.5
75% (p)
chi angles: 61.7
0.041Å--
A1097 GLY0-Favored (94.3%)
Glycine / -58.3,-42.2
----
A1098 ASP0-Favored (73.74%)
General case / -64.6,-30.4
99.2% (m-20)
chi angles: 288.1,165.7
0.004Å--
A1099 THR00.462Å
OG1 with A1095 SER CB
Favored (18.29%)
General case / -89.2,154.6
80.8% (p)
chi angles: 61.3
0.035Å--
A1100 VAL0-Favored (53.67%)
General case / -132.0,133.3
99.4% (t)
chi angles: 178.5
0.059Å--
A1101 VAL0-Favored (26.16%)
General case / -82.1,153.4
89.6% (t)
chi angles: 175.3
0.028Å--
Bond angles.
Avg: 0.00Clashscore: 54.81Outliers: 0 of 112Poor rotamers: 0 of 99Outliers: 0 of 106Outliers: 0 of 114Outliers: 2 of 114
A1102 TYR00.419Å
CG with A1103 GLN N
Favored (19.56%)
General case / -134.8,170.7
89.2% (t80)
chi angles: 181.4,77.7
0.021Å--
A1103 GLN00.419Å
N with A1102 TYR CG
Favored (47.44%)
General case / -67.6,133.9
66.4% (tt0)
chi angles: 185.2,176.6,12.4
0.03Å--
A1104 TYR0-Favored (48.01%)
General case / -95.6,129.6
31.9% (m-85)
chi angles: 292.7,71.8
0.015Å--
A1105 GLY0-Favored (55.24%)
Glycine / -77.7,-31.8
----
A1106 VAL00.507Å
CG2 with A1091 ILE CG1
Favored (63.47%)
General case / -122.8,129.5
90.2% (t)
chi angles: 177.9
0.04Å--
A1107 ALA0-Favored (18.5%)
General case / -88.8,154.6
-0.029Å--
A1108 THR0-Favored (59.01%)
General case / -119.5,136.0
95.7% (m)
chi angles: 299.7
0.042Å--
A1109 VAL00.745Å
CG1 with A1088 PHE CE2
Favored (59.39%)
General case / -127.7,129.6
99.2% (t)
chi angles: 178.5
0.04Å--
A1110 ILE0-Favored (62.75%)
General case / -114.8,130.0
91.7% (mt)
chi angles: 298.6,169.9
0.048Å--
A1111 ILE00.447Å
CG1 with A1052 PHE CZ
Favored (38.73%)
General case / -102.4,116.0
48.6% (mm)
chi angles: 304.2,301.2
0.043Å--
A1112 GLU0-Favored (37.42%)
General case / -80.3,137.7
88.2% (tt0)
chi angles: 184.6,177.6,2.2
0.035Å--
A1113 ALA0-Favored (33.84%)
General case / -84.5,139.7
-0.027Å--
A1114 ASN0-Favored (23.36%)
General case / -82.1,-41.9
66.2% (m-80)
chi angles: 287.6,281.9
0.029Å--
A1115 ASP0--47.8% (t0)
chi angles: 189.7,18
0.035Å--